These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34418452)

  • 81. D1R/PP2A/p-CaMKIIα signaling in the caudate putamen is involved in acute methamphetamine-induced hyperlocomotion.
    Shang Q; Xiao J; Gao B; Liang M; Wang J; Qian H; Xi Z; Li T; Liu X
    Neurosci Lett; 2021 Aug; 760():136102. PubMed ID: 34237414
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T
    J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice.
    Liang JH; Wang K; Sun HL; Han R
    Psychopharmacology (Berl); 2006 Mar; 185(1):1-10. PubMed ID: 16432683
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice.
    Itoh Y; Nishibori M; Oishi R; Saeki K
    Neurosci Lett; 1984 Aug; 48(3):305-9. PubMed ID: 6541326
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Feed intake after inhibition of histamine catabolism.
    Lecklin A; Tuomisto L
    Agents Actions; 1990 Apr; 30(1-2):216-9. PubMed ID: 2371925
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.
    Banks ML; Manvich DF; Bauzo RM; Howell LL
    Pharmacology; 2009; 83(3):164-9. PubMed ID: 19145102
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
    Gou H; Wen D; Ma C; Li M; Li Y; Zhang W; Liu L; Cong B
    Behav Brain Res; 2015 Apr; 283():87-96. PubMed ID: 25629941
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Genetic deletion of MT(1) and MT(2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice.
    Hutchinson AJ; Hudson RL; Dubocovich ML
    J Pineal Res; 2012 Nov; 53(4):399-409. PubMed ID: 22672659
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice.
    Raineri M; Peskin V; Goitia B; Taravini IR; Giorgeri S; Urbano FJ; Bisagno V
    Synapse; 2011 Oct; 65(10):1087-98. PubMed ID: 21590747
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats.
    Kitanaka N; Kitanaka J; Watabe K; Takemura M
    Neuroscience; 2010 Feb; 165(4):1370-6. PubMed ID: 19958817
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Alterations of accumbens neuronal activity in freely moving rats following methamphetamine.
    Fukuzako H; Nagatomo I; Nomaguchi M; Takenouchi K; Matsumoto K
    Jpn J Psychiatry Neurol; 1988 Jun; 42(2):331-5. PubMed ID: 2853805
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.
    Liao IM; Chen JC
    Behav Brain Res; 2021 Jan; 396():112925. PubMed ID: 32971195
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice.
    Kubota Y; Ito C; Sakurai E; Sakurai E; Watanabe T; Ohtsu H
    J Neurochem; 2002 Nov; 83(4):837-45. PubMed ID: 12421355
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
    Yamaguchi K; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Limonene inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal function and dopamine release.
    Yun J
    Phytomedicine; 2014 May; 21(6):883-7. PubMed ID: 24462212
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission.
    Ago Y; Araki R; Yano K; Hiramatsu N; Kawasaki T; Chaki S; Nakazato A; Onoe H; Hashimoto H; Baba A; Takuma K; Matsuda T
    Psychopharmacology (Berl); 2011 Oct; 217(3):443-52. PubMed ID: 21487651
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of no synthesis inhibition on striatal dopamine release and stereotyped behavior induced by a single administration of methamphetamine.
    Abekawa T; Ohmori T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):831-8. PubMed ID: 9278954
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Differential effects of chronic adolescent glucocorticoid or methamphetamine on drug-induced locomotor hyperactivity and disruption of prepulse inhibition in adulthood in mice.
    Schonfeld L; Jaehne EJ; Ogden AR; Spiers JG; Hogarth S; van den Buuse M
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jul; 117():110552. PubMed ID: 35337859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.